Identification of Human Antigen-Specific CD4


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 1 6 2019
pubmed: 31 5 2019
medline: 23 1 2020
Statut: ppublish

Résumé

The development of peptide-MHC class II multimers has provided a novel approach in studying antigen-specific CD4

Identifiants

pubmed: 31147953
doi: 10.1007/978-1-4939-9450-2_26
doi:

Substances chimiques

Antigens 0
Epitopes 0
HLA-DRB4 Chains 0
Histocompatibility Antigens Class II 0
Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

375-386

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400049C
Pays : United States

Auteurs

Ying Ying Kong (YY)

Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.

William W Kwok (WW)

Benaroya Research Institute at Virginia Mason, Seattle, WA, USA. bkwok@benaroyaresearch.org.
Department of Medicine, University of Washington, Seattle, WA, USA. bkwok@benaroyaresearch.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH